Joseph W Kim
5PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 27, 2024
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors.Yiduo Hu, Azeet Narayan, Yunshan Xu
|Nov 14, 2022
Effect of Androgen-Androgen Receptor Directed Therapy on COVID-19 Outcome in Prostate Cancer Patients.Serhan Ünlü, Junghee Jenny Shin, Jennefer Par-Young
|Oct 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984.Joseph W Kim, Rana R McKay, Marc R Radke
|Aug 05, 2022
Emerging Role of PARP Inhibitors in Metastatic Prostate Cancer.Serhan Unlu, Joseph W Kim
|Mar 20, 2021
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation.Joseph W Kim, Dana B Cardin, Ulka N Vaishampayan
Pageof 1
Frequent Collaborators
2 joint publications
S Percy Ivy
2 joint publications
Serhan Unlu
1 joint publications
Rana R McKay
1 joint publications
Marc R Radke
1 joint publications
Shilin Zhao
1 joint publications
Nancy B Davis
1 joint publications
Leonard J Appleman
1 joint publications
Primo N Lara
1 joint publications
Ulka N Vaishampayan
1 joint publications
Jingsong Zhang
